These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14174038)

  • 1. POTENTIAL CARCINOLYTIC AGENTS RELATED TO CYCLOPHOSPHAMIDE.
    FRIEDMAN OM; PAPANASTASSIOU ZB; LEVI RS; TILL HR; WHALEY WM
    J Med Chem; 1963 Jan; 6():82-3. PubMed ID: 14174038
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential carcinolytic agents. VI. New deactivated biological alkylating agents.
    Papanastassiou ZB; Bruni RJ; White E
    Experientia; 1968 Apr; 24(4):325. PubMed ID: 5748444
    [No Abstract]   [Full Text] [Related]  

  • 3. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID.
    DEGRAW J; GOODMAN L
    J Med Chem; 1964 Mar; 7():213-5. PubMed ID: 14187378
    [No Abstract]   [Full Text] [Related]  

  • 4. POTENTIAL ANTICANCER AGENTS. LXXIX. AROMATIC NITROGEN MUSTARDS DERIVED FROM CYSTEINE.
    IWAMOTO RH; ACTON EM; ROSS LO; SKINNER WA; BAKER BR; GOODMAN L
    J Med Chem; 1963 Jan; 6():43-6. PubMed ID: 14174029
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECTS OF URACIL MUSTARD ON IN VIVO INCORPORATION OF PRECURSORS INTO NUCLEIC ACIDS OF THE WALKER TUMOR.
    SMITH SJ; BUSCH H
    Tex Rep Biol Med; 1964; 22():731-40. PubMed ID: 14226996
    [No Abstract]   [Full Text] [Related]  

  • 6. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H; SILL AD
    Arzneimittelforschung; 1964 Feb; 14():150-1. PubMed ID: 14229652
    [No Abstract]   [Full Text] [Related]  

  • 7. ETHYL N-BENZYLLEUCINATE NITROGEN MUSTARD.
    SMITH HE; COOK SL
    J Med Chem; 1964 Sep; 7():680-1. PubMed ID: 14233193
    [No Abstract]   [Full Text] [Related]  

  • 8. INTRALUMINAL CHEMOTHERAPY WITH NITROGEN MUSTARD IN SIMULATED CANCER OF THE COLON IN THE RAT.
    GROSSI CE; COLE DR; ROUSSELOT LM
    J Surg Res; 1964 Jul; 4():334-6. PubMed ID: 14214452
    [No Abstract]   [Full Text] [Related]  

  • 9. NITROGEN MUSTARDS DERIVED FROM 3,4-DIHYDRO-2, 4-DIOXO-1(2H)-PYRIMIDINEPROPIONIC AND -BUTYRIC ACIDS.
    MARTINEZ AP; LEE WW; GOODMAN L
    J Med Chem; 1965 Mar; 8():187-9. PubMed ID: 14332657
    [No Abstract]   [Full Text] [Related]  

  • 10. SYNTHESIS AND STUDIES OF OPTICALLY ACTIVE CHLOROETHYLAMINE DERIVATIVES OF DIPEPTIDES.
    SOPHINA ZP; LARIONOV LF; SCHKODINSKAIA EN; VASINA OS; BERLIN AJ
    Acta Unio Int Contra Cancrum; 1964; 20():82-6. PubMed ID: 14151989
    [No Abstract]   [Full Text] [Related]  

  • 11. ARYL-2-HALOGENOALKYLARYLAMINES. XXI. THE DESIGN OF AGENTS TO EXPLOIT DIFFERENCES IN CELLULAR OXIDATION-REDUCTION POTENTIALS.
    ROSS WC
    Biochem Pharmacol; 1964 Jul; 13():969-82. PubMed ID: 14201139
    [No Abstract]   [Full Text] [Related]  

  • 12. POLYPEPTIDES FROM P-PHENYLALANINE MUSTARD.
    MOSHER CW; IWAMOTO RH; ACTON EM; GOODMAN L
    J Med Chem; 1964 Sep; 7():650-2. PubMed ID: 14233180
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF GLUCOSE PRETREATMENT ON THE CARCINOSTATIC AND TOXIC ACTIVITIES OF SOME ALKYLATING AGENTS.
    CONNORS TA; MITCHLEY BC; ROSENOER VM; ROSS WC
    Biochem Pharmacol; 1964 Mar; 13():395-400. PubMed ID: 14157601
    [No Abstract]   [Full Text] [Related]  

  • 14. SYNTHESIS OF 6- AND 7-BIS(2-CHLOROETHYL)AMINO-DL-TRYPTOPHAN.
    GOODMAN L; SPENCER RR; CASINI G; CREWS OP; REIST EJ
    J Med Chem; 1965 Mar; 8():251-2. PubMed ID: 14332671
    [No Abstract]   [Full Text] [Related]  

  • 15. RESEARCHES ON THE SYNTHESIS OF SOME NEW HORMONO-CYTOSTATIC COMPOUNDS, AND ON THE EFFECT OF THESE SUBSTANCES IN THE EXPERIMENTAL CANCER.
    MILCU S; ZIMEL H; PETREA I
    Acta Unio Int Contra Cancrum; 1964; 20():91-5. PubMed ID: 14151991
    [No Abstract]   [Full Text] [Related]  

  • 16. [INHIBITION OF THE RESPIRATORY ACTIVITY IN SOME EXPERIMENTAL TUMORS UNDER THE INFLUENCE OF NITROGEN MUSTARD].
    SANTORO M; CAPPELLI L
    Oncologia; 1964; 18():171-7. PubMed ID: 14220364
    [No Abstract]   [Full Text] [Related]  

  • 17. I. RATIONAL APPROACHES TO THE DEVELOPMENT OF ANTICANCER DRUGS. POSSIBLE IMPROVEMENTS OF CYTOTOXIC AGENTS.
    ROSS WC
    Acta Unio Int Contra Cancrum; 1964; 20():33-6. PubMed ID: 14151924
    [No Abstract]   [Full Text] [Related]  

  • 18. CYANO ANALOGS OF PHENOLIC NITROGEN MUSTARDS.
    BURKE WJ; BROWN JE; WEATHERBEE C; CURTIS DH
    J Med Chem; 1964 Sep; 7():670-1. PubMed ID: 14233188
    [No Abstract]   [Full Text] [Related]  

  • 19. HEXAHYDROPYRIMIDINES. IV. SYNTHESIS OF 2-(4-(N,N-BIS(2-CHLOROETHYL)AMINO)ARYL)-1,3-BIS(ARALKYL)HEXAHYDROPYRIMIDINES AS ANTITUMOR AGENTS.
    BILLMAN JH; MEISENHEIMER JL
    J Med Chem; 1964 Jan; 7():115-7. PubMed ID: 14186011
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL CHROMOSOME ALTERATIONS DUE TO CYCLOPHOSPHAMIDE AND URACIL-MUSTARD].
    BALLERINI G; BOSI L; PARESCHI PL; PUNTURIERI E
    Arcisp S Anna Ferrara; 1964; 17():1139-52. PubMed ID: 14265725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.